Q4 2019 13F Holders as of 12/31/2019
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
31.6M
-
Number of holders
-
133
-
Total 13F shares, excl. options
-
31.5M
-
Shares change
-
+1.2M
-
Total reported value, excl. options
-
$648M
-
Value change
-
+$50.5M
-
Put/Call ratio
-
0.2
-
Number of buys
-
72
-
Number of sells
-
-60
-
Price
-
$20.58
Significant Holders of COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) as of Q4 2019
157 filings reported holding COLL - COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share as of Q4 2019.
COLLEGIUM PHARMACEUTICAL, INC - Common Stock, par value $0.001 per share (COLL) has 133 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.5M shares
of 31.6M outstanding shares and own 99.75% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (4.5M shares), BlackRock Inc. (2.57M shares), EVENTIDE ASSET MANAGEMENT, LLC (2.43M shares), FRAZIER MANAGEMENT LLC (1.89M shares), FRANKLIN RESOURCES INC (1.77M shares), VANGUARD GROUP INC (1.68M shares), Rock Springs Capital Management LP (1.58M shares), RENAISSANCE TECHNOLOGIES LLC (1.25M shares), RICE HALL JAMES & ASSOCIATES, LLC (1.06M shares), and EMERALD ADVISERS, LLC (781K shares).
This table shows the top 133 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.